These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30224317)

  • 1. Chronic use of statins and risk of post-ERCP acute pancreatitis (STARK): Study protocol for an international multicenter prospective cohort study.
    Korpela T; Cárdenas-Jaén K; Archibugi L; Poropat G; Maisonneuve P; Arcidiacono PG; De Pretis N; Löhr M; Capurso G; de-Madaria E
    Dig Liver Dis; 2018 Dec; 50(12):1362-1365. PubMed ID: 30224317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study.
    Cárdenas-Jaén K; Archibugi L; Poropat G; Korpela T; Maisonneuve P; Aparicio JR; Udd M; Stimac D; Arcidiacono PG; De Pretis N; Valente R; Di Giulio E; Casellas JA; Kylänpää L; Hauser G; Mariani A; Gabbrielli A; Löhr M; Vanella G; Rainio M; Brozzi L; Arnelo U; Fagerström N; Capurso G; de-Madaria E
    Dig Endosc; 2021 May; 33(4):639-647. PubMed ID: 32713065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin consumption and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Martínez-Moneo E; Cárdenas-Jaén K; Fernández-Laso AB; Millastre-Bocos J; Torralba-Gallego A; Martín-Arriero S; Alfaro-Almajano E; García-Rayado G; de-Madaria E
    Pancreatology; 2020 Jul; 20(5):801-805. PubMed ID: 32448748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced risk of post ERCP pancreatitis in statin users.
    Hadi YB; Naqvi SF; Abdelqader A; Kupec J; Nasr J
    BMC Gastroenterol; 2020 Apr; 20(1):125. PubMed ID: 32326889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular Statin Use and Incidence of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Hakuta R; Nakai Y; Hamada T; Suzuki Y; Inokuma A; Oyama H; Kanai S; Nakamura T; Sato T; Ishigaki K; Saito K; Saito T; Takahara N; Mizuno S; Kogure H; Tada M; Koike K
    J Clin Gastroenterol; 2020; 54(10):905-910. PubMed ID: 31895166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Matsumoto T; Okuwaki K; Imaizumi H; Kida M; Iwai T; Yamauchi H; Kaneko T; Hasegawa R; Masutani H; Tadehara M; Adachi K; Watanabe M; Kurosu T; Tamaki A; Kikuchi H; Ohno T; Koizumi W
    Dig Dis Sci; 2021 Dec; 66(12):4475-4484. PubMed ID: 33495919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
    Law R; Leal C; Dayyeh BA; Leise MD; Balderramo D; Baron TH; Cardenas A
    Liver Transpl; 2013 Dec; 19(12):1354-60. PubMed ID: 24115362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic use of statins and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis.
    Facciorusso A; Crinò SF; Tacelli M; Antonini F; Fantin A; Barresi L
    Expert Rev Gastroenterol Hepatol; 2021 Feb; 15(2):195-202. PubMed ID: 32993442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postendoscopic retrograde cholangiopancreatography pancreatitis.
    Shih HY; Hsu WH; Kuo CH
    Kaohsiung J Med Sci; 2019 Apr; 35(4):195-201. PubMed ID: 30887733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal INdomethacin, oral TacROlimus, or their combination for the prevention of post-ERCP pancreatitis (INTRO Trial): Protocol for a randomized, controlled, double-blinded trial.
    Akshintala VS; Husain SZ; Brenner TA; Singh A; Singh VK; Khashab MA; Sperna Weiland CJ; van Geenen EJM; Bush N; Barakat M; Srivastava A; Kochhar R; Talukdar R; Rodge G; Wu CCH; Lakhtakia S; Sinha SK; Goenka MK; Reddy DN
    Pancreatology; 2022 Nov; 22(7):887-893. PubMed ID: 35872074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use does not decrease the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Facciorusso A; Buccino VR; Tonti P; Sacco R
    Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):511-513. PubMed ID: 32462964
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.
    Smeets XJNM; da Costa DW; Fockens P; Mulder CJJ; Timmer R; Kievit W; Zegers M; Bruno MJ; Besselink MGH; Vleggaar FP; van der Hulst RWM; Poen AC; Heine GDN; Venneman NG; Kolkman JJ; Baak LC; Römkens TEH; van Dijk SM; Hallensleben NDL; van de Vrie W; Seerden TCJ; Tan ACITL; Voorburg AMCJ; Poley JW; Witteman BJ; Bhalla A; Hadithi M; Thijs WJ; Schwartz MP; Vrolijk JM; Verdonk RC; van Delft F; Keulemans Y; van Goor H; Drenth JPH; van Geenen EJM;
    Trials; 2018 Apr; 19(1):207. PubMed ID: 29606135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Raw Rhubarb Solution in the Precaution of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Patients with High-Risk Factors: A Predictive Random Compared Research in One Center.
    Wang C; Li Q; Ye P; Zeng S; Li GH; Chen YX; Zhou XJ; Lv NH
    Dig Dis Sci; 2017 Apr; 62(4):1043-1050. PubMed ID: 28194668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of body weight on fixed dose of diclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Leerhøy B; Nordholm-Carstensen A; Novovic S; Hansen MB; Jørgensen LN
    Scand J Gastroenterol; 2016 Aug; 51(8):1007-12. PubMed ID: 27160512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.
    Zhou W; Li Y; Zhang Q; Li X; Meng W; Zhang L; Zhang H; Zhu K; Zhu X
    Pancreatology; 2011; 11(4):399-405. PubMed ID: 21894057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early precut sphincterotomy for difficult biliary access to reduce post-ERCP pancreatitis: a randomized trial.
    Mariani A; Di Leo M; Giardullo N; Giussani A; Marini M; Buffoli F; Cipolletta L; Radaelli F; Ravelli P; Lombardi G; D'Onofrio V; Macchiarelli R; Iiritano E; Le Grazie M; Pantaleo G; Testoni PA
    Endoscopy; 2016 Jun; 48(6):530-5. PubMed ID: 26990509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of advanced age on post-ERCP pancreatitis and unplanned hospitalisation.
    Maitin-Casalis N; Neeman T; Thomson A
    Intern Med J; 2015 Oct; 45(10):1020-5. PubMed ID: 26122669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.